Page last updated: 2024-08-18

4-butyrolactone and Adenocarcinoma, Endometrioid

4-butyrolactone has been researched along with Adenocarcinoma, Endometrioid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iida, K; Ishibashi, T; Ishikawa, M; Katagiri, A; Katagiri, H; Miyazaki, K; Nakayama, K; Rahman, M; Rahman, MT	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Adenocarcinoma, Endometrioid

Article	Year
Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer. Oncology, 2013, Volume: 84, Issue:3 Topics: 4-Butyrolactone; Blotting, Western; Carcinoma, Endometrioid; Cell Proliferation; Endometrial Neoplasms; Fatty Acid Synthase, Type I; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Staging; Prognosis; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survival Rate; Tumor Cells, Cultured	2013

Article

Year

Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.

Oncology, 2013, Volume: 84, Issue:3

Topics: 4-Butyrolactone; Blotting, Western; Carcinoma, Endometrioid; Cell Proliferation; Endometrial Neoplasms; Fatty Acid Synthase, Type I; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Middle Aged; Neoplasm Staging; Prognosis; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Survival Rate; Tumor Cells, Cultured

2013